RRM2B and ovarian cancer: We suggest that increased p48, p53R2, Gaad45 and sestrin mRNA levels, due to DMU-214 treatment, might be considered a mechanism of defence triggered in A-2780 ovarian cancer cells as a response to the insult evoked by the cytotoxic agent.